Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 28628 | 203 | 22.2 | 45% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
| 176 | 3 | DIABETES CARE//ENDOCRINOLOGY & METABOLISM//TYPE 2 DIABETES | 58057 |
| 79 | 2 | DIABETES CARE//DIABETES EDUCATOR//DIABETIC MEDICINE | 27337 |
| 28628 | 1 | CLINICAL PRACTICE RESEARCH DATALINK CPRD//REGIME AMPI//THE HEALTH IMPROVEMENT NETWORK THIN | 203 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | CLINICAL PRACTICE RESEARCH DATALINK CPRD | authKW | 200560 | 1% | 67% | 2 |
| 2 | REGIME AMPI | address | 200560 | 1% | 67% | 2 |
| 3 | THE HEALTH IMPROVEMENT NETWORK THIN | authKW | 200560 | 1% | 67% | 2 |
| 4 | ANTIDIABETIC DRUG CONSUMPTION | authKW | 150421 | 0% | 100% | 1 |
| 5 | ANTIDIABETIC DRUG USE | authKW | 150421 | 0% | 100% | 1 |
| 6 | ANTIDIABETIC DRUG UTILISATION | authKW | 150421 | 0% | 100% | 1 |
| 7 | ANTIHYPERGLYCAEMIC DRUG UTILISATION | authKW | 150421 | 0% | 100% | 1 |
| 8 | BIBLIOMETRIES | authKW | 150421 | 0% | 100% | 1 |
| 9 | CHROMOSOMES 14 19 21 | authKW | 150421 | 0% | 100% | 1 |
| 10 | CJF 93 06 | address | 150421 | 0% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Endocrinology & Metabolism | 1284 | 31% | 0% | 63 |
| 2 | Pharmacology & Pharmacy | 288 | 24% | 0% | 48 |
| 3 | Medicine, General & Internal | 201 | 16% | 0% | 32 |
| 4 | Public, Environmental & Occupational Health | 152 | 12% | 0% | 25 |
| 5 | Primary Health Care | 115 | 2% | 0% | 5 |
| 6 | Substance Abuse | 48 | 2% | 0% | 5 |
| 7 | Clinical Neurology | 31 | 7% | 0% | 14 |
| 8 | Psychology | 26 | 3% | 0% | 6 |
| 9 | Neurosciences | 13 | 7% | 0% | 15 |
| 10 | Psychiatry | 8 | 3% | 0% | 7 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | REGIME AMPI | 200560 | 1% | 67% | 2 |
| 2 | CJF 93 06 | 150421 | 0% | 100% | 1 |
| 3 | COM PEDAG | 150421 | 0% | 100% | 1 |
| 4 | CONTROLE MED DENTAIRE LEGISLAT SOCIALES AGR | 150421 | 0% | 100% | 1 |
| 5 | DIRECC ATENC PRIMARIA SALUD | 150421 | 0% | 100% | 1 |
| 6 | DIRECT MED CARDIOVASC DIABETE | 150421 | 0% | 100% | 1 |
| 7 | HEALTHMETR OUTCOMES | 150421 | 0% | 100% | 1 |
| 8 | MED CONSEIL REG ADJOINT | 150421 | 0% | 100% | 1 |
| 9 | MED GEN MED FAMILLE | 150421 | 0% | 100% | 1 |
| 10 | MEDWHO ABORAT DRUG UTILISAT | 150421 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | DIABETES & METABOLISM | 72538 | 18% | 1% | 37 |
| 2 | ACTIVITAS NERVOSA SUPERIOR | 26538 | 6% | 1% | 13 |
| 3 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 5442 | 8% | 0% | 16 |
| 4 | REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE | 4434 | 3% | 0% | 7 |
| 5 | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 3182 | 3% | 0% | 7 |
| 6 | ANNALES MEDICO-PSYCHOLOGIQUES | 2526 | 3% | 0% | 6 |
| 7 | JOURNAL OF CLINICAL AND HOSPITAL PHARMACY | 2393 | 1% | 1% | 2 |
| 8 | DIABETES-METABOLISM REVIEWS | 1943 | 1% | 1% | 2 |
| 9 | INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES | 1392 | 1% | 0% | 2 |
| 10 | NEW ENGLAND AND REGIONAL ALLERGY PROCEEDINGS | 1231 | 0% | 1% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | RICORDEAU, P , WEILL, A , VALLIER, N , BOURREL, R , FENDER, P , ALLEMAND, H , (2000) EPIDEMIOLOGY OF DIABETES IN MAINLAND FRANCE.DIABETES & METABOLISM. VOL. 26. ISSUE . P. 11-24 | 9 | 90% | 49 |
| 2 | VAUZELLE-KERVROEDAN, F , FORHAN, A , JAVOY, F , FENDER, P , ESCHWEGE, E , (1999) PHARMACOEPIDEMIOLOGY OF DIABETES PERFORMED BY THE FRENCH HEALTHCARE SYSTEM DATA.DIABETES & METABOLISM. VOL. 25. ISSUE 2. P. 163-171 | 9 | 75% | 5 |
| 3 | GOURDY, P , RUIDAVETS, JB , FERRIERES, J , DUCIMETIERE, P , AMOUYEL, P , ARVEILER, D , COTTEL, D , LAMAMY, N , BINGHAM, A , HANAIRE-BROUTIN, H , (2001) PREVALENCE OF TYPE 2 DIABETES AND IMPAIRED FASTING GLUCOSE IN THE MIDDLE-AGED POPULATION OF THREE FRENCH REGIONS - THE MONICA STUDY 1995-97.DIABETES & METABOLISM. VOL. 27. ISSUE 3. P. 347 -354 | 10 | 53% | 24 |
| 4 | DETOURNAY, B , VAUZELLE-KERVROEDAN, F , CHARLES, MA , FORHAN, A , FAGNANI, F , FENDER, P , ESCHWEGE, E , (1999) EPIDEMIOLOGY, MANAGEMENT AND COSTS OF TYPE 2 DIABETES IN FRANCE IN 1998.DIABETES & METABOLISM. VOL. 25. ISSUE 4. P. 356 -365 | 10 | 56% | 25 |
| 5 | VAUZELLE-KERVROEDAN, F , CHEROU-DEBREGEAS, S , FORHAN, A , FENDER, P , ESCHWEGE, E , (2000) TOTALLY REIMBURSED CARE FOR TYPE 2 DIABETES IN 1994: CHARACTERISTICS AND FOLLOW-UP.DIABETES & METABOLISM. VOL. 26. ISSUE . P. 55-62 | 6 | 86% | 4 |
| 6 | DA SILVA, GB , DA SILVA, GB , FENDER, P , BRUNEL, M , ALLEMAND, H , (1999) REGIONAL PREVALENCE OF PSYCHIATRIC AFFECTIONS AS SEEN IN NATIONAL HEALTH INSURANCE MEMBERS.ANNALES MEDICO-PSYCHOLOGIQUES. VOL. 157. ISSUE 10. P. 700-713 | 5 | 100% | 0 |
| 7 | KLEINEBREIL, L , DURLACH, V , (1998) FIVE YEARS OF DIABCARE-FRANCE: ASSESSEMENT AND PERSPECTIVES..DIABETES & METABOLISM. VOL. 24. ISSUE . P. 8 -12 | 4 | 100% | 1 |
| 8 | RESI, D , CASTELVETRI, C , VACCHERI, A , MONTANARO, N , (2001) THE THERAPEUTIC COURSE AS A MEASURE COMPLEMENTARY TO DEFINED DAILY DOSES WHEN STUDYING EXPOSURE TO ANTIBACTERIAL AGENTS.EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 57. ISSUE 2. P. 177-180 | 5 | 71% | 2 |
| 9 | CHARPENTIER, G , GENES, N , VAUR, L , AMAR, J , CLERSON, P , CAMBOU, JP , GUERET, P , (2003) CONTROL OF DIABETES AND CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH TYPE 2 DIABETES: A NATIONWIDE FRENCH SURVEY.DIABETES & METABOLISM. VOL. 29. ISSUE 2. P. 152-158 | 6 | 50% | 46 |
| 10 | MARTINEZ-LORENZI, E , DESJEUX, G , MARSAN, P , THEVENIN-GARRON, V , (2013) INCIDENCE OF THIRTY CHRONIC DISEASES IN THE FRENCH ARMED FORCES BETWEEN 2005 AND 2011.SANTE PUBLIQUE. VOL. 25. ISSUE 5. P. 599-607 | 2 | 100% | 0 |
Classes with closest relation at Level 1 |